INTRODUCTION
Cancer results from a complex interplay between gene regulation and its environment. Microbial communities inhabiting our intestine and other portals of entry represent unappreciated environmental factors that appear to play a role in intestinal and extraintestinal carcinogenesis (Zitvogel et al., 2015) . Pioneering studies performed in germ-free and gnotobiotic animals or in antibiotic-treated rodents revealed an unsuspected role of commensals in tumorigenesis. In the colon cancer or hepatocarcinoma, microbes can directly be transforming agents (Sears and Garrett, 2014) by providing a toxic metabolite, an oncogenic product or inducing an inflammatory milieu which will culminate in genomic instability and/or DNA damage responses and/or immune escape (Gur et al., 2015; Louis et al., 2014) . A role for Tolllike receptor 5-dependent commensal microbes in interleukin-6 (IL-6) or IL-17-driven systemic inflammation was demonstrated in extraintestinal neoplasia (Rutkowski et al., 2015) . In contrast, other observations support a beneficial role of distinct bacteria against cancer. Prolonged exposure to a combination of metronidazole and ciprofloxacine tripled breast cancer (BC) occurrence in protooncogene HER2/neu driven-transgenic mice (Rossini et al., 2006) . In humans, epidemiological studies suggested a dose-dependent association between antibiotic use and risk of BC (Blaser, 2011; Velicer et al., 2004) . The beneficial role of the intestinal microbiota was first reported by Paulos et al. showing that total body irradiation promoted a LPS-TLR4-dependent activation of antigen-presenting cells facilitating the efficacy of adoptive T cell transfer (Paulos et al., 2007) . Next, Iida et al. reported that bacteria-associated TLR4 agonists accounted for the ROS and TNF-a-mediated antitumor effects of tumor infiltrating myeloid cells (MDSC) during platinum-based anticancer therapies and immunomodulatory regimen (Iida et al., 2013) . We also showed that cyclophosphamide (CTX) promoted the translocation of distinct Gram + bacteria (mainly Lactobacillus johnsonii and Enterococcus hirae) that mounted effector pathogenic Th17 (pTh17) cell responses associated with tumor control (Viaud et al., 2013) . We and others showed that distinct intestinal bacterial species belonging to Bacteroidales and Burkholderiales or Bifidobacteriales orders influenced the tumor microenvironment, contributing to the efficacy of anti-CTLA4 or anti-PDL-1 Ab, respectively Sivan et al., 2015) . Hence, the intestinal microbiota ecosystem might control not only the gut immune homeostasis but also the inflammatory and/or immune tone of secondary lymphoid organs, culminating in shaping the tumor microenvironment. This hypothesis implies that anticancer therapeutics alter the delicate mutualistic symbiosis between intestinal epithelial cells, the local microbiome, and the lamina propria resident-immune system, contributing to reprogram anticancer immune responses. The precise identification of bacterial genera capable of linking intestinal and anti-cancer immune responses is key to the emerging field of ''oncomicrobiotics'' (OMBs), i.e., immunogenic commensals influencing the host-cancer equilibrium.
Here, we identified two intestinal OMBs, namely E. hirae and Barnesiella intestinihominis, that both act to orchestrate the anticancer therapeutic effects of CTX. The small intestineresident Gram + bacteria E. hirae induces systemic pTh17 cell responses associated with tumor antigen-specific, MHC class I-restricted cytotoxic T cells (CTL) and increased intratumoral CTL/T regulatory (Treg) cell ratio. 
RESULTS

E. hirae Restored the Efficacy of CTX in AntibioticsTreated Mice
We previously reported that broad spectrum antibiotics (ATBs) and vancomycin decreased the anticancer activity of CTX in vivo. We then showed that CTX compromised the integrity of the intestinal epithelium, promoting the translocation of distinct Gram + bacteria in secondary lymphoid organs that could elicit L. johnsonii or E. hirae specific Th1 cell responses (Viaud et al., 2013 Figure 1A ). Broad spectrum ATBs prevented the metronomic CTX-mediated control of tumor growth ( Figure 1B ). However, oral gavage with E. hirae clone 13144 selectively restored the CTX-mediated antitumor effects whereas our L. johnsonii, E. coli, or Lactobacilli isolates failed to do so ( Figures 1C and 1D ).
To assess the effective colonization by E. hirae, we performed ex vivo cultivation of feces on agar plates (followed by mass spectrometry identification of bacteria), qPCR with enterococci-specific probes, and FISH analyses of mucosal and luminal compartments at various locations of the small and large intestine. These assays concluded that by 24 hr post-gavage, all detectable bacteria were E. hirae, which were very abundant in the jejunum and ileum and were not only present in the lumen but also in the mucosa for at least 4 days (Figures S1A-S1D). Additionally, supplementation with E. hirae (and not colonization with a Gram-bacteria residing in the colon such as B. intestinihominis) induced the proliferation of gdT cells and CD8 + T cells residing in the epithelial layer ( Figure 1E ( Figures 1H and 1I ) associated with a slight reduction of the antimicrobial peptide RegIIIg ( Figure 1J ). We next analyzed the immunological effects of E. hirae in the secondary lymphoid organs of naive animals. Six days after bacterial colonization, we harvested splenocytes to perform a flow cytometric analyses focusing on IFN-g + and/or IL-17 + , as well as CXCR3 + and/or CCR6 + T cells (Figure 2A Figures 2C and S2A) , polarization corroborated by cell sorting and qPCR detecting Tbx21 and Il21 gene expression ( Figure S2B) . We tested various E. hirae isolates derived from human, mouse, or environmental ecosystems to analyze their differential immunogenicity in vivo and their capacity to mediate ''oncomicrobiotic'' property. These strains, which were equally susceptible to antimicrobial agents (Table  S1 ), failed to produce virulence gene products (such as cob, cylA, efaA efm , efaA efs , cpd, cylB, ccf, gel, esp, agg, cylM, copZ) as opposed to pathogenic Enterococcus faecalis. Of note, E. hirae 13144 (the isolate we cultivated from mouse spleens post-CTX) failed to exhibit virulence in the in vivo infection model Galleria mellonella (Figure S2D) . The investigation of clonal relationship between these E. hirae isolates by rep-PCR revealed an important genomic diversity within these strains ( Figure S2C ). Half of the isolates induced pTh17 and Th1 immune responses ( Figure 2D ) with only one human isolate (clone 708) exhibiting Tc1 potential in naive mice associated with OMB properties ( Figure 1D , data not shown). The only human isolate of E. hirae (clone EH17) capable of forming ex vivo biofilms on adherence assays harbored no immunogenic nor OMB properties (Figures 1D and 2D and S2E) . We next re-examined these immunogenic properties in the setting of a growing sarcoma MCA205 known to influence the gut microbiome (Viaud et al., 2013) (Figure 2E ). In tumor bearers, E. hirae 13144 induced Th17 and pTh17 but not Th1 immune responses ( Figure 2F ), suggesting that inflammatory cytokines (such as TGF-b, IL-6, IL-1b, IL-23) involved in pTh17 cell differentiation may fluctuate with the tumor bulk. Of note, the poorly immunogenic E. hirae clone EH17 did not induce high IL-1b secretion levels from dendritic cells ex vivo (as opposed to clone 13144 or clone 708) ( Figure S3 ).
Thus, E. hirae exerts a capacity to induce pTh17 cells in secondary lymphoid organs of CTX-treated and dysbiotic animals, associated with its OMBs properties.
E. hirae Enhanced Cognate Anticancer Immune Responses
To investigate whether E. hirae-associated systemic immune responses could promote anti-tumor cognate T cell responses, we set up two distinct preclinical models. First, tumor cell lines genetically modified to express the ovalbumine antigen (OVA) were implanted subcutaneously (s.c.) following a 14-day-broad spectrum ATBs therapy. Then, animals were adoptively transferred with OVA 323-339 specific MHC class II-restricted OTII TCR transgenic T cells and treated with CTX ( Figure 3A ). We monitored the immunological impact of an oral gavage with E. hirae on the activation of congenic CD45.2 + OTII cells in the spleen. In contrast to syngenic CD45.1 + T cells, which differentiated into Th17 cells ( Figure 2E ), OTII transgenic T were geared toward Th1 cells following colonization with E. hirae 13144 (Figures 3B and 3C) . Next, we used a s.c. TC1 model expressing the human papillomavirus 16 (HPV16) E7 (Vingert et al., 2006) in which tumor regression could be obtained by vaccinating mice using a non-replicative delivery system composed of the B subunit of Shiga toxin coupled to E7 antigen (STxB-E7) ( Figure 3D ). This immunization protocol elicited polyfunctional D b -E7 [39] [40] [41] [42] [43] [44] [45] [46] [47] tetramer binding CD8 + T cells (Sandoval et al., 2013) . Interestingly, the combination of STxB-E7 and CTX (''vaccine'') was synergistic, eventually leading to complete tumor eradication ( Figure 3E ). Here again, a negative impact of broad spectrum ATBs on the efficacy of the ''vaccine'' was observed with a marked reduction of complete tumor rejection rates in ATBscompared with water-treated groups ( Figures 3E and 3F ). Next, we monitored the impact of an oral gavage with E. hirae on the probability of complete cure and on the expansion of polyfunctional D b -E7 39-47 tetramer binding CD8 + T cells in the spleens post-ATBs. Indeed, E. hirae compensated the lack of efficacy of the cancer ''vaccine'' in ATBs-treated mice ( Figure 3F ) with or without the use of STxB-E7 (data not shown) and restored, in ATBs-treated mice, the expansion of D b -E7 [39] [40] [41] [42] [43] [44] [45] [46] [47] tetramer binding CD8 + T cells observed in naive mice CTXtreated positive controls ( Figure 3G ). Thus, mono-association of ''gut sterilized'' mice with E. hirae could partially restore CTX-induced anticancer Th1 cell or CTL responses, keeping in check tumor progression.
Porphyromonadaceae Family Members (genus Barnesiella) Are Involved in the Long-Term Immunogenicity of CTX We previously showed that CTX could induce Gram + bacteria translocation (Viaud et al., 2013) . To analyze the potential impact of the major pattern-recognition receptors in Gram + bacterial translocation to the mesenteric LN or spleen, we screened Myd88-, TLR2-, TLR4-, TLR2xTLR4-, and NOD1xNOD2-deficient mice for the presence of cultivatable commensals in secondary lymphoid organs at 48 hr post-CTX. We found a significant increase of bacterial translocation in these Nod1
Nod2
À/À mice ( Figure 4A and data not shown). We next monitored tumor growth kinetics in MCA205-bearing WT versus Nod1
À/À C57BL/6 mice. The CTX antitumor efficacy was markedly enhanced in Nod1
compared with age matched controls bred in the same animal facility ( Figure 4B ). We phenocopied these effects using pharmacomimetics, i.e., agonists for NOD1 and NOD2 receptors, namely the peptidoglycans MurNAc-L-Ala-g-D-Glu-mDAP (TriDAP) and muramyl dipeptide in WT mice, respectively. These compounds reduced CTX-mediated pTh17 cells in the spleen ( Figure 4C , left panel). This was found to be associated with increased intestinal release of the antimicrobial peptide lipocalin-2 in stools that might in turn facilitate epithelial repair and reduction of intestinal permeability ( Figure 4C , right panel). Consequently, we performed pyrosequencing analyses of 16S rRNA gene amplicons from both the mucosa of the small intestine and stools harvested from naive WT mice versus their Nod1 À/À Nod2 À/À littermates 7 days post-CTX. Principle component analyses revealed that bacterial community structures were significantly different between CTX groups from WT versus gene deficient mice for the families and genera at both locations (Figures 4D , S4, and Table S2 for the OTU). There was an overrepresentation of Clostridiaceae in the small intestines ( Figure S4C ), mainly attributable to segmented filamentous bacteria (Table  S2) Figure S4 and Table S2 .
mice exhibiting a superior anticancer response to CTX than WT mice, we addressed the role of Gram À bacteria in the adjuvant effect of CTX in the context of a vaccine comprising a cognate cancer antigen, such as the OVA+polyI:C-based cancer immunization procedure ( Figure 4G ). Indeed, broad spectrum ATBs, as well as colistin, prevented the long-term protection of this cancer vaccine against the lethal challenge with OVA-engineered MC38 tumor cells ( Figure 4H Figure 4I ). Altogether, distinct Porphyromonadaceae family members (genus Barnesiella) were overrepresented in the large intestine of CTX-treated mice in conditions of NOD1 and NOD2 functional deficiencies, which might be relevant to account for long-term memory Tc1 cell immune responses protective against tumor establishment.
Considering that two commensals, E. hirae or B. intestinihominis, appeared regulated either by translocation or accumulation in feces immediately after CTX administration, we next addressed whether they could modulate systemic and local tumor immunity in the absence of ATBs-induced dysbiosis ( Figure 5A ). Both OMBs induced an inversion of the CD4/CD8 T cell ratio in the spleen, facilitating the accumulation of effector CD8 + T cells (Figures S5A and 5B) . Whereas E. hirae maintained its capacity to induce pTh17 in the spleen in the absence of ATBs (Figure S5C) , B. intestinihominis induced polyfunctional CD4 + Th1 and CD8 + Tc1 cells ( Figure S5D ). Importantly, E. hirae markedly reduced the numbers of regulatory Foxp3 + CD25 + CD4 + tumor infiltrating lymphocytes (TILs), increasing the CTL/Treg cell ratio ( Figures 5B and 5C ), whereas B. intestinihominis augmented the proportions of IFN-g-producing gdTILs while decreasing IL-17-producing gdTILs, the latter phenomenon being also observed with the other OMBs ( Figure 5D ). Repetitive gavages of either OMBs ( Figure 5E ) were markedly effective in ameliorating the CTX activity against MCA205 fibrosarcoma ( Figure 5F ). Interestingly, gavages with B. intestinihominis was also effective against Ret melanoma ( Figure 5G ). Of note, in the absence of CTX, E. hirae was not able to impact the natural tumor growth of MCA205 sarcoma (Figures S5E and S5F) . The neutralization of IFN-g (but not that of IL-17) or the depletion of Figure 6A ), indicating that intestinal NOD2 is a gate keeper normally preventing E. hirae translocation. The immune-dependent anti-sarcoma effects mediated by CTX were not ameliorated in Nod1
À/À mice compared with WT counterparts but were markedly enhanced in Nod2 À/À mice ( Figures 6B, S6A , and 6B). Accordingly, we phenocopied these effects using NOD2 receptor agonists, the peptidoglycans muramyl dipeptide inhibiting the antitumor effects of CTX in WT littermates ( Figure S6C , left panel) while the TriDAP failed to have any effect (Figure S6C, right panel) . Moreover, CTX-treated sarcoma growing in Nod2 À/À mice contained fewer Treg cells ( Figure 6C , left panels) and higher proportions of innate IFN-g-producing gdTILs compared with sarcoma growing in WT counterparts ( Figure 6C , right panels). These findings were reminiscent of the bioactivity observed with the ''enforced'' colonization by E. hirae and B. intestinihominis, respectively, in WT animals. To validate this assumption, we performed a gavage of Nod2 À/À tumor-bearing mice with each OMB and monitored TILs by flow cytometry (Figure 6D) . Both OMBs induced an increase in CD8 + CTLs (Figure 6E, left panel) , but E. hirae increased the CTL/Treg ratio ; villin-Cre + and Cre À conditional mice were treated with tamoxifen and were orally gavaged with E. hirae prior to and right after 100 mg/kg of CTX ip. Mesenteric LN or spleen were cultivated 48 hr later as in Figure 4A . The number of colonies identified by mass spectrometry as being E. hirae per plate are depicted (Cre + versus Cre À ). Of note, there was also an increase of the percentages of positive plates (data not shown).
(B). Tumor growth curves after administration of CTX (as in Figure 4B To analyze the role of NOD2 receptors expressed by intestinal epithelial cells (IECs), we reduced the model system to cryptderived 3D-small intestine enteroids generated from intestinal stem cells harvested from WT versus Nod2 À/À mice . While short-term incubation of enteroids with mafosfamide (the active metabolite of the prodrug CTX) at the pharmacologically active concentration did not promote a NOD2-dependent apoptosis of IECs, E. hirae and B. intestinihominis rapidly induced cell demise of IECs, in a NOD2-dependent manner. Of note, L. johnsonii also induced IECs death independently of NOD2 ( Figure 6F ). Quantitative PCR analyses investigating the transcriptional oscillations of various gene products (IL-18, Bax, but not LysP and Grp78) involved in intestinal homeostasis corroborated the protective role of NOD2 receptors against the toxicity of these immunogenic bacteria ( Figure 6G and data not shown) (Nigro et al., 2014) . Finally, conditional knockout mice expressing a transgenic recombinase in IECs under the control of a villin promoter with defective expression of NOD2 confirmed that IECs-associated NOD2 deficiency is necessary and sufficient to account for CTX-induced accumulation of pTh17 and gdT cells in the spleens ( Figure 6H ).
These findings suggest that IEC NOD2 receptors represent ''gut immune checkpoints'' restricting the immunogenicity of distinct Gram + and Gram À bacteria. (Table S3 ). Culture supernatants of monocytes and memory CD4 + T cells were monitored for IFN-g and IL-10 secretion levels after restimulation with distinct commensals. Segregating the first cohort of lung cancers according to the median of IFN-g produced by bacteria-specific memory T cells revealed that memory Th1 cells recognizing E. hirae and B. intestinihominis post-platinum based-chemotherapy predicted longer PFS, while Th1 cell recall responses toward other bacteria were not clinically relevant (Figures 7A and 7B and S7A) . A second univariate analysis was performed by adding 13 advanced ovarian cancer patients resistant to platinum-based chemotherapy and treated with metronomic CTX. In this larger cohort, memory Th1 cells directed against E. hirae were the only protective T cell responses ( Figure 7C ). However, considering the ratio between IFN-g and IL-10 release following stimulation, B. intestinihominis allowed to reach statistical significance for prolonged PFS in the whole cohort of advanced cancer patients (Figures 7D and 7E and S7B) .
DISCUSSION
Here we identified key bacterial species involved in the immunomodulatory effects of CTX, a major pillar of adjuvanticity used in a variety of immunotherapeutic protocols (Le et al., 2015; Lee et al., 2015; Sistigu et al., 2011) . We showed that bacterial species belonging to two genera, Enterococcus and Barnesiella, were necessary and sufficient to mount effector and memory cancer-specific CD4 + and CD8 + T cells, thereby compensating for the loss or limited efficacy of CTX observed during ATBs-or cancer-induced dysbiosis, respectively. The era of probiotics and microbiotherapy has come of age with the emergence of inflammatory disorders caused by an overt deviation of the gut microbiome (Cotillard et al., 2013; Kassam et al., 2013; Le Chatelier et al., 2013; Moayyedi et al., 2015) . Although cancer-associated dysbiosis has not yet been characterized, one can anticipate that the host-microbe mutualism be disturbed in cancer bearers, for instance during chemotherapy-induced mucositis (Zitvogel et al., 2015) , IEC-killing during CTLA4 blockade (Beck et al., 2006; Berman et al., 2010; Vé tizou et al., 2015) or IEC damage and bacterial translocation during CTX therapy, exacerbated in the context of NOD2 deficiency as shown here. E. hirae was capable of decreasing Treg, gdT17 cells, and increased CD8 + effector TILs, reinstating antitumor CTL activity). Most of the immunological (loss of DC and Th17 subsets) and inflammatory changes (increased proportions of Paneth cells) observed in the lamina propria (LP) during CTX metronomic therapy were observed in the small intestine, primarily in the duodenum and ileum (Viaud et al., 2013) which represent major colonization sites for enterococci (Ghosh et al., 2013) . A high density of E. hirae (which tolerated gastric conditions and high bile salt concentrations) was found associated with a significant bactericidal effect against enteric pathogens (such as Vibrio cholerae, E. faecalis, Enterobacter aerogenes, Pseudomonas aeruginosa, E. coli, and Salmonella Typhi) (Arokiyaraj et al., 2014) and compete against E. coli, hereby preventing diarrhea in young kittens (Ghosh et al., 2013) . The production of bacteriocins (such as hiracin JM79) by E. hirae facilitated the niche control in the intestine (Nes et al., 2014) . However, the consequences of oral feeding with a commensal like E. hirae on the equilibrium of the small intestinal ecosystem remain to be elucidated. Of interest, we found a Gram À bacterium ameliorating the effects of CTX, exerting different immunological effects on systemic and anticancer immune responses than E. hirae. Hence, sequencing analyses of feces from mice exhibiting a better response to CTX in the absence of NOD receptors highlighted the overrepresentation of the Barnesiella genus at the expense of Lachnospiraceae family members. The abundance of Barnesiella in the colon correlated with several other immunoregulatory cells such as marginal zone B cells and invariant NKT in the spleen and liver (Presley et al., 2010) . The Barnesiella genus correlated with the clearance of vancomycin-resistant Enterococcus faecium in mice (Ubeda et al., 2013) . In addition, Barnesiella densities were abnormally elevated in HIV-infected compared with non-infected individuals and associated with systemic inflammation (Dinh et al., 2015) . Supporting this notion, B. intestinihominis was found overrepresented after ionizing radiation causing oxidative DNA damage, a therapeutic context where intestinal microbiota has a protective role (Maier et al., 2014 What could be the mechanisms supporting why such commensals represent suitable OMBs? First, the geodistribution of such commensals might be crucial to enable access by intestinal phagocytes subsets to the immunogenic bacterium. Mucosal (as opposed to luminal) commensals or crypt-residing bacteria might be obvious candidates to regulate local and systemic immune responses (Farache et al., 2013; Palm et al., 2014; Pé dron et al., 2012) . Second, the deterministic model proposed by Littman and colleagues for Th cell differentiation in the intestine based on the bacterial context of cognate antigen delivery dictating the fate of antigen-specific T cells might hold true in our context, given the correlation between the capacity of clones of E. hirae to mount strong pTh17 immune responses and their OMB effect. E. hirae electively induced IL-6, IL-1b, and IL-23 in ex vivo propagated DC, cytokines involved in the pTh17 differentiation. Indeed, such an inflammatory or immunogenic profile of E. hirae 13144 appeared highly protective in cancer patients. End-stage cancer patients resistant to platinum-based chemotherapy exhibited longer PFS when harboring prominent Th1 memory responses directed against E. hirae (or B. intestinihominis). Third, bacterial products might change the immunological tone of lymphoid organs (Ganal et al., 2012) or tumor beds (Iida et al., 2013) , facilitating the elicitation of cancer antigen-specific T cells. Hence, Iida et al. exemplified that TLR4 was important for the efficacy of platinum salts in modulating intratumoral MDSC and inducing antitumor effects and demonstrated that LPS could partially compensate for the reduced tumoricidal activity of oxaliplatine in ATB-treated mice (Iida et al., 2013) . Fourth, given that some bacteria (such as E. hirae and B. intestinihominis) are electively kept in check by NOD2 receptors, it is conceivable that loss-of-function mutations of NOD2 gene and impaired expression of NOD2 gate keepers in pathological circumstances will facilitate the elicitation of immune responses against these commensals/pathobionts. Fifth, bacteria-specific adaptive immune responses primed in mesenteric LN might express an array of chemokine receptors that dictate their homing to inflammatory lesions to reinstate local immunity (Bartman et al., 2015; Viaud et al., 2013) . Hence, interruption of the CCR9/CCL25 axis promoted the growth of CCL25 producing Figure S7 and Table S3 .
tumors by limiting the accumulation of CD4 + Th cells in tumor draining lymph nodes (Jacquelot et al., 2016) . Finally, a potential molecular mimicry between distinct commensals/pathobionts and tumor antigens is conceivable but remains to be established (Rubio-Godoy et al., 2002) .
This study represents the rationale to reconstitute an optimal microbiota diversity integrating important species of the Enterococcus and Barnesiella genera to optimize the response to at least alkylating agents, currently employed in breast cancers, sarcomas, hematopoietic and pediatric malignancies. Altogether, these findings open the perspective of developing OMBs or their bacterial products (MAMPS or metabolites) to optimize cancer therapies (Zitvogel et al., 2015) and open the question as to whether any OMB could fit any cytotoxicant. We surmise that the near future will undoubtedly unravel new OMBs suitable for other therapeutic compounds with their peculiar mode of action.
EXPERIMENTAL PROCEDURES Mice
All animal experiments were carried out in compliance with the French and European laws and regulations. Mice were used between 7 and 16 weeks of age. WT specific pathogen-free C57BL/6J mice were obtained from Harlan (France) and were kept in SPF conditions in the animal facility of Gustave Roussy, Villejuif, France. Nod1
